Dermatology

Non-genetic factors such as age, allergies, smoking, and prior history of angioedema may significantly increase the risk of angioedema in patients taking ACE inhibitors or angiotensin receptor blockers, according to new pharmaco-epidemiological research.

New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and long-term outcomes remain key research needs.

Dermatological conditions in polar environments are gaining new attention as research missions to the Arctic and Antarctic expand.

Persistent acne scarring remains a major concern for patients and clinicians alike, with many individuals turning to invasive procedures in search of effective relief.

Biologic therapies targeting interleukin (IL)-17 and IL-23 have transformed the treatment landscape for plaque psoriasis, but questions remain about how these therapies perform in elderly patients compared to younger adults.

In dermatology research, the use of race and ethnicity as population descriptors has come under increasing scrutiny, with experts questioning whether these broad categories obscure more than they reveal about human health.

Healthcare professionals treating conditions such as peripheral neuropathy, wound ulcers, or radiation dermatitis now have fresh, evidence-based guidance on the use of photobiomodulation (PBM) therapy.

Radiologic imaging in high-risk cutaneous squamous cell carcinoma (cSCC) has proven more valuable than previously recognized, uncovering unexpected findings in nearly half of patients and prompting significant changes in treatment, according to a major retrospective study.